CPT only copyright 2011 American Medical Association. Page 2 of 5 What You Need to Know This article explains the difference between a National Provider Identifier (NPI) and a Provider Transaction Access Number (PTAN). There are no policy changes in this article.
For people with aggressive B cell non-Hodgkin lymphoma, we commonly recommend a chemotherapy treatment called R-CHOP. It is named after the medicines included in the mixture: rituximab (RituxanÂ®), a monoclonal antibody that helps your immune system destroy the cancer cells and makes the chemotherapy more powerful
The majority of patients who are diagnosed with Hodgkin lymphoma (HL) will be cured with primary treatment; however, approximately 10% of patients with localized classical HL and approximately 30% with disseminated classical HL relapse after primary conventional treatment with chemotherapy, alone or combined with radiotherapy.